In addition, they showed that the A1AT level was >100 mg/dL in 83% of Pi*MZ patients with A1AT deficiency-associated cirrhosis, thus suggesting that underlying liver inflammation can falsely elevate the A1AT level as part of the acute phase response.7. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.